Rheumatoid arthritis (RA) is caused by the immune system mistakenly attacking the tissue lining your joints, but what triggers that immune malfunction isn’t one single thing. It’s a chain reaction involving your genes, environmental exposures like smoking, infections, and changes in your gut bacteria, all building on each other over months or years before you ever notice a swollen joint.
Understanding these causes matters because RA doesn’t appear out of nowhere. It develops in stages, and many of the contributing factors are identifiable, some even modifiable, long before the disease takes hold.
Genetics Set the Stage
Your genes don’t guarantee you’ll develop RA, but they heavily influence your odds. The strongest genetic link involves a set of immune system genes that help your body distinguish its own proteins from foreign invaders. A specific genetic signature called the “shared epitope,” found on certain immune-related genes, appears in roughly 70% of people who develop the most common form of RA. People who inherit two copies of this marker face the highest risk.
Family history tells a similar story. If you have a parent or sibling with RA, your odds of developing it are about three times higher than average. Having a sibling with RA raises that slightly further, to about 3.6 times. And if two or more first-degree relatives have been diagnosed, the risk jumps to roughly seven times the general population’s. Even second-degree relatives (aunts, uncles, grandparents) raise your risk by about twofold.
But genetics alone aren’t enough. Plenty of people carry these risk genes and never develop RA. Something in the environment has to pull the trigger.
How Smoking Ignites the Process
Cigarette smoking is the single strongest environmental risk factor for RA, and researchers now understand the biological chain of events that explains why. The connection centers on a chemical change called citrullination, where the body’s own proteins get slightly altered. Normally, this is a routine cellular process. But in the lungs of smokers, it goes into overdrive.
Tobacco smoke damages airway cells, causing them to die and release their contents, including citrullinated proteins. Smoking also ramps up the enzymes responsible for citrullination in lung tissue, flooding the area with these modified proteins. In someone who carries the shared epitope genes, the immune system is primed to react badly to these proteins. Immune cells grab the citrullinated proteins, present them to other immune cells, and kick off an antibody response directed against the body’s own tissues.
The antibodies produced in this process are called anti-citrullinated protein antibodies, or ACPA. These autoantibodies are highly specific to RA. They can be detected in the blood years before any joint symptoms appear, and they show up in about two-thirds of RA patients at diagnosis. Their specificity for RA is around 95%, meaning they rarely show up in people with other conditions.
The Role of Infections and Gum Disease
A bacterium responsible for periodontitis (chronic gum disease) has drawn significant attention as a potential RA trigger. This organism produces its own version of the same enzyme that citrullinates human proteins, and it’s the only known bacterium that does so. In laboratory studies, infection with this bacterium significantly increased levels of autoantibodies against both collagen (a joint protein) and citrullinated proteins. When researchers tested a mutant version of the bacterium that lacked the citrullinating enzyme, the immune response didn’t happen, confirming that the enzyme is what drives the problem.
What makes this bacterial enzyme particularly troublesome is that it works differently from the human version. It can modify proteins in environments where the human enzyme cannot, meaning it can generate altered proteins in places the body doesn’t expect them. These altered proteins look foreign to the immune system, potentially breaking the tolerance that normally prevents your body from attacking itself.
Gut Bacteria and Early Immune Changes
Your intestinal microbiome also appears to play a role. Three independent studies across Japan, the United States, and the United Kingdom have found an association between a gut bacterium in the Prevotella genus and rheumatoid arthritis. The initial discovery came from studying treatment-naive patients with brand-new RA, where this bacterium was overrepresented in their intestines compared to healthy people. Follow-up research showed increased immune reactivity to this organism among RA patients.
When researchers gave this bacterium to germ-free mice, their arthritis worsened, supporting the idea that the relationship is causal rather than coincidental. Perhaps most intriguing, one study found this bacterium associated with preclinical RA in asymptomatic first-degree relatives of RA patients, suggesting that gut changes may happen early in the disease process, before symptoms begin. The exact mechanism linking gut bacteria to joint inflammation is still being worked out, and geographical factors seem to influence which specific bacterial strains are involved.
What Happens Inside Your Joints
Once the immune system has been activated against citrullinated proteins, the damage eventually arrives at the joints. The synovial membrane, a thin tissue lining the inside of your joint capsule, becomes the primary battlefield. Immune cells infiltrate this membrane and begin releasing inflammatory signaling molecules called cytokines. Three cytokines do most of the damage, each produced by different cells within the inflamed joint lining.
Cells on the surface of the synovial lining, the layer directly facing the joint cavity, pump out two of these cytokines that trigger pain, swelling, and the production of enzymes that break down cartilage. These same surface cells stimulate deeper cells in the tissue to release a third cytokine that amplifies the inflammatory cascade further. All three work together, each making the others more potent. The result is a thickened, inflamed synovial membrane that gradually erodes cartilage and bone from within the joint.
This isn’t a quick process. The synovial lining can become aggressively inflamed, almost behaving like a growing tissue that invades and destroys the cartilage and bone it was originally meant to protect.
Why Women Are Affected More Often
Women develop RA two to three times more often than men, and the incidence in women has been gradually increasing in recent decades. The reasons for this disparity aren’t fully understood, but hormonal differences are the leading hypothesis. RA often first appears during periods of hormonal change: after pregnancy, during perimenopause, or in early menopause. Some women experience remission during pregnancy, when certain hormone levels are elevated, only to flare after delivery.
Sex differences also affect how the disease behaves. The immune system in women is generally more reactive than in men, which provides better defense against infections but also creates more vulnerability to autoimmune conditions across the board, not just RA.
RA Develops in Stages
Rheumatoid arthritis is now understood as a multistep process that unfolds over years, not something that switches on overnight. Researchers describe it as an iceberg: the joint swelling and pain that lead to a diagnosis are just the visible tip.
The first stage is purely genetic risk, when someone carries susceptibility genes but has no immune abnormalities. The second stage involves a break in immune tolerance, often driven by environmental exposures like smoking or infections, where the body begins producing autoantibodies like ACPA and rheumatoid factor. This can happen five to ten years before any symptoms. The third stage brings symptoms like joint pain and stiffness without visible joint swelling, a phase sometimes called “clinically suspect arthralgia.” Only in the final stage does full clinical arthritis appear, with the characteristic swollen, warm, and tender joints.
This staged model is why someone with joint pain and a family history of RA might be tested for ACPA. Detecting autoantibodies before clinical arthritis develops opens a window where the disease may be easier to manage, since joint damage hasn’t yet begun. The term “pre-clinical RA” is technically applied only in hindsight, once someone has progressed to full disease, but recognizing earlier stages is increasingly part of clinical practice.
Other Contributing Risk Factors
Beyond genetics, smoking, infections, and gut health, several other factors influence RA risk:
- Obesity: Excess body fat produces its own inflammatory signals that can contribute to immune dysregulation. Higher body weight is associated with increased RA risk, particularly in women.
- Air pollution and silica dust: Occupational exposure to silica and living in areas with high particulate air pollution have both been linked to higher RA rates, likely through the same lung-based citrullination pathway triggered by smoking.
- Age: RA most commonly begins between ages 40 and 60, though it can start at any age.
No single cause explains every case of RA. The disease emerges from a collision of inherited vulnerability, immune-activating exposures, and the body’s inflammatory response spiraling out of control. For most people, it takes multiple hits across these categories before the disease crosses the threshold into clinical reality.